New Sysco Solutions Partner, Square, Brings Time-Saving, Easy-To-Use Technology to More Restaurants
December 18, 2024 08:00 ET
|
Sysco Corporation
HOUSTON, Dec. 18, 2024 (GLOBE NEWSWIRE) -- Today, Sysco Corporation (NYSE:SYY), the world’s largest food distributor, announced a new partnership with Square to help restaurants of all sizes succeed...
Neutrolis Expands Senior Leadership Team to Drive Development of Growing Pipeline of Non-Immunosuppressive Therapies for NET-mediated Autoimmune Diseases
December 18, 2024 08:00 ET
|
Neutrolis, Inc.
CAMBRIDGE, Mass., Dec. 18, 2024 (GLOBE NEWSWIRE) -- Neutrolis Inc., a clinical stage biotech company focused on targeting Neutrophil Extracellular Traps (NETs) for the treatment of autoimmune and...
Smart Sensors Market to Worth USD 187.41 Billion by 2032 Driven by Advancements in IoT and Automation | Research by SNS Insider
December 18, 2024 08:00 ET
|
SNS Insider pvt ltd
Austin, Dec. 18, 2024 (GLOBE NEWSWIRE) -- Market Size & Growth Analysis: The SNS Insider report indicates that,“The Smart Sensors Market was valued at USD 50.89 billion in 2023 and is estimated...
3D Cell Culture Market Size Projected to Surpass Reaching USD 4.0 Billion by 2032 with 12.4% CAGR – Research by SNS Insider
December 18, 2024 08:00 ET
|
SNS Insider pvt ltd
Pune, Dec. 18, 2024 (GLOBE NEWSWIRE) -- 3D Cell Culture Market Size & Growth Analysis: “According to SNS Insider, the global 3D Cell Culture Market, valued at USD 1.4 billion in 2023, is...
GraniteShares launches new YieldBoost ETF on Tesla (TSYY)
December 18, 2024 08:00 ET
|
GraniteShares
GraniteShares YieldBOOSTTM TSLA ETF Fund (TSYY) NEW YORK, Dec. 18, 2024 (GLOBE NEWSWIRE) -- Today, GraniteShares, an ETF issuer specializing in high conviction ETFs, announced that it has launched...
ARS Pharmaceuticals to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
December 18, 2024 08:00 ET
|
ARS Pharmaceuticals, Inc.
SAN DIEGO, Dec. 18, 2024 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect...
Raadr (Doing Business as Telvantis) Announces $45 Million Working Capital Facility to Drive Accelerated Growth
December 18, 2024 08:00 ET
|
Telvantis Inc.
NEW YORK, Dec. 18, 2024 (GLOBE NEWSWIRE) -- Raadr, Inc., now doing business as Telvantis (OTC PINK: RDAR) ("Telvantis" or the "Company"), is excited to announce the establishment of a new $45...
MBX Biosciences to Participate in 43rd Annual J.P. Morgan Healthcare Conference
December 18, 2024 08:00 ET
|
MBX Biosciences, Inc.
CARMEL, Ind., Dec. 18, 2024 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide...
SCYNEXIS Initiates Dosing in Phase 1 Trial of SCY-247, a Second-Generation Fungerp Candidate for Invasive Fungal Infections
December 18, 2024 08:00 ET
|
Scynexis
JERSEY CITY, N.J., Dec. 18, 2024 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and...
ViGeneron Announces FDA Clearance of IND for Novel mRNA Trans-Splicing Gene Therapy VG801 to Treat Stargardt Disease and Other ABCA4-Linked Retinal Dystrophies
December 18, 2024 08:00 ET
|
ViGeneron GmbH
VG801 is the first FDA IND clearance for novel mRNA trans-splicing gene therapy, delivering the full-length functional ABCA4 gene to target the genetic root cause of retinal dystrophies associated...
- January 11, 2025 16:15 ET HII Christens Amphibious Transport Dock Harrisburg (LPD 30)
- January 11, 2025 15:19 ET BDTCOIN Launches on Tier 1 Exchanges: Unlock New Investment Opportunities in Web3 and AI